Related Experiment Video
Updated: Oct 11, 2025

06:11
Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
Published on: May 2, 2025
239
Combination Therapy for a Severe Axillary Keloid with Abscesses: A Case Report
Teruyuki Dohi1, Hoyu Cho1, Mina Kamegai1
1Department of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
|November 29, 2021
Summary
A rare case of a giant keloid, a fibroproliferative skin disorder, was successfully treated. This combination therapy involved surgery, radiotherapy, and steroid-plaster treatment, offering hope for severe keloid management.
Area of Science:
- Dermatology
- Plastic Surgery
- Oncology
Background:
- Keloids are fibroproliferative disorders causing significant motor function limitation and painful infections.
- Severe keloids can spread widely, posing a challenge for effective treatment.
- Giant keloids, like the one described, require innovative therapeutic approaches.
Observation:
- A patient presented with a giant keloid originating from a childhood vaccination site, which had grown extensively over decades.
- The keloid caused significant cosmetic disfigurement, pain, and restricted movement.
- Initial suspicion of malignancy was ruled out by biopsy, confirming a diagnosis of a giant keloid.
Findings:
- A combination therapy involving partial surgical resection with local flap transposition, followed by radiotherapy and steroid-plaster treatment, was implemented.
- Postoperative radiotherapy and 18 months of steroid-tape therapy were administered to the residual keloid.
- At 18 months post-treatment, no recurrence was observed, with complete resolution of pain and movement restriction.
Implications:
- This case suggests that a multimodal approach combining surgery, radiotherapy, and steroid therapy can be effective for managing severe and extensive keloids.
- The treatment improved the patient's quality of life significantly.
- Further research is needed to establish a standard treatment protocol for severe keloid cases.
